𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Recurrent copy number gains of ACVR1 and corresponding transcript overexpression are associated with survival in head and neck squamous cell carcinomas

✍ Scribed by Eliane P Ambrosio; Sandra A Drigo; Nádia A Bérgamo; Fabíola E Rosa; Fernanda B Bertonha; Francine B de Abreu; Luis P Kowalski; Silvia R Rogatto

Book ID
108781092
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
231 KB
Volume
59
Category
Article
ISSN
0309-0167

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Recurrent copy number gain of transcript
Recurrent copy number gain of transcription factor SOX2 and corresponding high protein expression in oral squamous cell carcinoma
✍ Kolja Freier; Karl Knoepfle; Christa Flechtenmacher; Susanne Pungs; Frauke Deven 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 337 KB

## Abstract Gene copy number aberrations are involved in oral squamous cell carcinoma (OSCC) development. To delineate candidate genes inside critical chromosomal regions, array‐CGH was applied to 40 OSCC specimens using a microarray covering the whole human genome with an average resolution of 1 M

DNA copy number variation and loss of he
DNA copy number variation and loss of heterozygosity in relation to recurrence of and survival from head and neck squamous cell carcinoma: A review
✍ Yu Chen; Chu Chen 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB 👁 2 views

## Abstract Genetic aberrations, such as DNA copy number variation (CNV) and loss of heterozygosity (LOH), have been implicated in head and neck squamous cell carcinoma (HNSCC) initiation and progression. This review examines CNV and LOH as predictors of HNSCC recurrence and mortality. We searched

High serum levels of YKL-40 in patients
High serum levels of YKL-40 in patients with squamous cell carcinoma of the head and neck are associated with short survival
✍ Anne Roslind; Julia S. Johansen; Ib J. Christensen; Katalin Kiss; Eva Balslev; D 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 273 KB 👁 2 views

## Abstract YKL‐40 is a glycoprotein secreted by macrophages, neutrophils and malignant tumor cells. Elevated serum levels of YKL‐40 are associated with poor prognosis in several malignancies. In this study, we examined the prognostic value of serum YKL‐40 before treatment and during follow‐up in p